Results 71 to 80 of about 5,998 (173)

Bumetanide Therapeutic Effect in Children and Adolescents With Autism Spectrum Disorder: A Review Study

Basic and Clinical Neuroscience, 2019
Introduction: Autism Spectrum Disorder (ASD) is characterized by several impairments in communications and social interactions, as well as restricted interests or stereotyped behaviors.
Raheleh Mollajani, Mohamad Taghi Joghataei, Mehdi Tehrani-doost   +2 more
doaj  

Effects of antihypertensive agents on Alzheimer’s disease biomarkers in hypertensive rats with experimentally induced Alzheimer’s

Zanco Journal of Medical Sciences
Background and objective: The most common cause of dementia in the elderly is Alzheimer's disease (AD). Numerous research studies have demonstrated a connection between hypertension (HTN) and the risk of developing AD.
Marwan Qasim Nadir, Rojgar Hamed Ali
doaj   +1 more source

Dim light at night induces cardiac injury in zebrafish embryos via disrupted chloride homeostasis. [PDF]

iScience
Chen R, Zeng Y, Min M, Xu K, Wang J, Liu T, Zhao Y, Zhang W, Cheng S, Zhang Y, Wang C, Deng D, Xiao X.   +12 more
europepmc   +1 more source

Diuretic inhibition of experimental myopia implicates retinal ion-driven efflux in the regulation of ocular growth. [PDF]

Front Med (Lausanne)
Murphy MJ, Riddell N, Crewther DP, Ignacio BM, Crewther SG.   +4 more
europepmc   +1 more source

A case for intranasal bumetanide for the management of heart failure. [PDF]

ESC Heart Fail
Danyluk A, McVeigh T, Nenadic I, Rushakoff J, Kittipibul M, Fudim M.   +5 more
europepmc   +1 more source

Minimizing in Source Fragmentation for Mass Spectrometry Based NDSRI Analytical Procedures: A Case Study of Nitroso-bumetanide. [PDF]

AAPS J
Zhang J, Shih M, Yang J, Keire DA, Xu X, Faustino PJ.   +5 more
europepmc   +1 more source

Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy. [PDF]

Signal Transduct Target Ther
Deiman FE, Bömer N, Davidsson P, Später D, Linders AN, Dias IB, Arevalo Gomez KF, Esquivel Gaytan A, Zhu J, Walentinsson A, Engberg S, Hattersley N, Etal D, Ahlstrom C, Mullick AE, Hansson KM, Silljé HHW, Grote Beverborg N, van der Meer P.   +18 more
europepmc   +1 more source

Bumetanide‑blocked SLC12A2 exerts a protective effect in experimental diabetic retinopathy. [PDF]

Int J Mol Med
Zhang Y, Wang X, Xie Q, Huang Y, Huang D, Liu Z, Xu T, Ni M, Yang H.   +8 more
europepmc   +1 more source

Efficacy of bumetanide for cognitive improvement in children and adolescents with Down syndrome: study protocol of a randomised, double-blind, placebo-controlled trial. [PDF]

BMJ Open
Costanzo F, Mongiovì VM, Alfieri P, Pontrelli G, Abbate S, De Palma L, Chinali M, Massella L, Scorpecci A, Rocchi F, Fucà E, Averna R, Rava L, Rossetti S, Franco L, Contestabile A, Cancedda L, Vicari S.   +17 more
europepmc   +1 more source

Treating autism with Bumetanide: Identification of responders using Q-Finder machine learning algorithm. [PDF]

Transl Psychiatry
Rabiei H, Begnis M, Lemonnier E, Ben-Ari Y.   +3 more
europepmc   +1 more source